These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 1452299)

  • 21. Cortical and medullary hemodynamics in deoxycorticosterone acetate-salt hypertensive mice.
    Gross V; Lippoldt A; Bohlender J; Bader M; Hansson A; Luft FC
    J Am Soc Nephrol; 1998 Mar; 9(3):346-54. PubMed ID: 9513896
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhanced expression of the endothelin-1 gene in blood vessels of DOCA-salt hypertensive rats: correlation with vascular structure.
    Schiffrin EL; Larivière R; Li JS; Sventek P
    J Vasc Res; 1996; 33(3):235-48. PubMed ID: 8924521
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Overflow of endogenous norepinephrine from PVH nucleus of DOCA-salt hypertensive rats.
    Qualy JM; Westfall TC
    Am J Physiol; 1995 Apr; 268(4 Pt 2):H1549-54. PubMed ID: 7733356
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of NO and angiotensin II in the early development of endothelial functions impairment and cardiac hypertrophy in deoxycorticosterone acetate-salt hypertension.
    K-Laflamme A; Oster L; Cardinal R; de Champlain J
    Can J Physiol Pharmacol; 1998 Jun; 76(6):665-75. PubMed ID: 9923405
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hemodynamics of dexamethasone-induced hypertension in the rat.
    Ong SL; Zhang Y; Sutton M; Whitworth JA
    Hypertens Res; 2009 Oct; 32(10):889-94. PubMed ID: 19644504
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiac type-1 angiotensin II receptor status in deoxycorticosterone acetate-salt hypertension in rats.
    Fareh J; Touyz RM; Schiffrin EL; Thibault G
    Hypertension; 1997 Nov; 30(5):1253-9. PubMed ID: 9369284
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Myocardial fibrosis in DOCA-salt hypertensive rats: effect of endothelin ET(A) receptor antagonism.
    Ammarguellat F; Larouche I; Schiffrin EL
    Circulation; 2001 Jan; 103(2):319-24. PubMed ID: 11208696
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunosuppression with mycophenolate mofetil attenuates the development of hypertension and albuminuria in deoxycorticosterone acetate-salt hypertensive rats.
    Boesen EI; Williams DL; Pollock JS; Pollock DM
    Clin Exp Pharmacol Physiol; 2010 Oct; 37(10):1016-22. PubMed ID: 20626757
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endothelin antagonist reduces hemodynamic responses to vasopressin in DOCA-salt hypertension.
    Yu M; Gopalakrishnan V; Wilson TW; McNeill JR
    Am J Physiol Heart Circ Physiol; 2001 Dec; 281(6):H2511-7. PubMed ID: 11709418
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased sensitivity to norepinephrine cardiac arrhythmias in the deoxycorticosterone acetate high salt rat before the onset of hypertension.
    Rabkin SW; Fung AY
    Can J Physiol Pharmacol; 1984 Jun; 62(6):605-9. PubMed ID: 6744105
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antihypertensive effects of chicken extract against deoxycorticosterone acetate-salt-induced hypertension in rats.
    Matsumura Y; Okui T; Ono H; Kiso Y; Tanaka T
    Biol Pharm Bull; 2001 Oct; 24(10):1181-4. PubMed ID: 11642328
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Central action of increased osmolality to support blood pressure in deoxycorticosterone acetate-salt rats.
    O'Donaughy TL; Qi Y; Brooks VL
    Hypertension; 2006 Oct; 48(4):658-63. PubMed ID: 16966581
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Atrial natriuretic factor content of brain nuclei in deoxycorticosterone acetate-salt hypertension in the rat.
    Geiger H; Bahner U; Palkovits M; Hupe J; Heidland A
    Clin Sci (Lond); 1989 Nov; 77(5):529-34. PubMed ID: 2531054
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Atrial natriuretic peptide receptors in renal papilla of DOCA-salt hypertensive rats.
    Nuglozeh E; Gauquelin G; Garcia R; Tremblay J; Schiffrin EL
    Am J Physiol; 1990 Jul; 259(1 Pt 2):F130-7. PubMed ID: 2165357
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Importance of renal sympathetic tone in the development of DOCA-salt hypertension in the rat.
    Katholi RE; Naftilan AJ; Oparil S
    Hypertension; 1980; 2(3):266-73. PubMed ID: 6993358
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ETA receptor blockade attenuates the hypertension but not renal dysfunction in DOCA-salt rats.
    Allcock GH; Venema RC; Pollock DM
    Am J Physiol; 1998 Jul; 275(1):R245-52. PubMed ID: 9688985
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impairment of neurally-mediated vasoconstriction in DOCA-salt hypertensive dogs.
    Hamed AT; Lokhandwala MF
    Clin Exp Hypertens A; 1982; 4(6):867-81. PubMed ID: 6284412
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of the antiglucocorticoid RU 486 in the prevention of steroid-induced hypertension.
    Opoku J; Kalimi M
    Acta Endocrinol (Copenh); 1992 Sep; 127(3):258-61. PubMed ID: 1414152
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Overexpression of Gi-proteins precedes the development of DOCA-salt-induced hypertension: relationship with adenylyl cyclase.
    Marcil J; de Champlain J; Anand-Srivastava MB
    Cardiovasc Res; 1998 Aug; 39(2):492-505. PubMed ID: 9798534
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Retardation of the development of hypertension in DOCA-salt rats by renal denervation.
    Takahashi H; Iyoda I; Yamasaki H; Takeda K; Okajima H; Sasaki S; Yoshimura M; Nakagawa M; Ijichi H
    Jpn Circ J; 1984 Jun; 48(6):567-74. PubMed ID: 6547490
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.